India To Keep Closer Eye On Clinical Trials To Identify Mortality Causes
This article was originally published in PharmAsia News
Clinical drug trials in India are to be monitored by health authorities for mortality rates in response to a World Health Organization report that Indian trials averaged more than one death per day.
You may also be interested in...
Abbott is launching a second test to detect COVID-19. The diagnostics giant announced on 27 March the release of a rapid, point-of-care test that can deliver results within five minutes.
President Trump on 27 March finally pulled the trigger on using his powers under the Defense Production Act, forcing General Motors Co. to manufacture medical ventilators. The only thing is, GM is already doing that.
Theradaptive's “paint-like” regenerative therapeutic can be applied to any device to promote bone regrowth or regenerate tissue.